Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund DR Horton Inc stake
total: 118
Parnassus Endeavor Fund DHI trades
- Total transactions:
- 9
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2022 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Parnassus Endeavor Fund doesn't hold any DR Horton Inc (DHI) shares. To date, the estimated cost basis is nearly $76.87 for "buy" trades and estimated average "sell" price is $126.24. Parnassus Endeavor Fund first purchased DHI in 2022 Q1, initially acquiring about 1.06M shares. Since the initial investment in DR Horton Inc (DHI), Parnassus Endeavor Fund has made 8 more transactions.
When did Parnassus Endeavor Fund sell DR Horton Inc (DHI)?
Parnassus Endeavor Fund sold off the entire DR Horton Inc (DHI) position in 2025 Q3.
When did Parnassus Endeavor Fund buy DR Horton Inc (DHI)?
Parnassus Endeavor Fund first invested in DR Horton Inc (DHI) in 2022 Q1 at the reported quarter-end price of $74.51 per share.
What's the cost basis of Parnassus Endeavor Fund's DHI stake?
The estimated cost basis for DR Horton Inc (DHI) stake is around $76.87 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $76.87
- Weighted AVG sell price:
- $126.24
Parnassus Endeavor Fund's historical trades in DR Horton Inc
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$128.92
|
|
-100% (-886,570)
|
-2.52%
|
|
2025 Q2
|
2.52%
|
886,570
|
$128.92
|
$114,296,604
|
+2.58% (+22,340)
|
+0.06%
|
|
2024 Q1
|
2.71%
|
864,230
|
$164.55
|
$142,209,046
|
-7.99% (-75,033)
|
-0.25%
|
|
2023 Q3
|
2.22%
|
939,263
|
$107.47
|
$100,942,595
|
-10.87% (-114,579)
|
-0.26%
|
|
2023 Q2
|
2.74%
|
1,053,842
|
$121.69
|
$128,242,033
|
-28.90% (-428,367)
|
-1.12%
|
|
2023 Q1
|
3.12%
|
1,482,209
|
$97.69
|
$144,796,997
|
-2.65% (-40,353)
|
-0.09%
|
|
2022 Q4
|
2.95%
|
1,522,562
|
$89.14
|
$135,721,177
|
+21.99% (+274,458)
|
+0.53%
|
|
2022 Q2
|
1.83%
|
1,248,104
|
$66.19
|
$82,612,004
|
+18.02% (+190,558)
|
+0.28%
|
|
2022 Q1
|
1.46%
|
1,057,546
|
$74.51
|
$78,797,752
|
new
|
+1.46%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.